- Home
- EWTX vs ESTA Comparison
EWTX vs ESTA Comparison
Compare EWTX & ESTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWTX
- ESTA
- Stock Information
- Founded
- EWTX 2017
- ESTA 2004
- Country
- EWTX United States
- ESTA Costa Rica
- Employees
- EWTX N/A
- ESTA N/A
- Industry
- EWTX Biotechnology: Pharmaceutical Preparations
- ESTA Industrial Specialties
- Sector
- EWTX Health Care
- ESTA Health Care
- Exchange
- EWTX Nasdaq
- ESTA Nasdaq
- Market Cap
- EWTX 1.5B
- ESTA 982.3M
- IPO Year
- EWTX 2021
- ESTA 2018
- Fundamental
- Price
- EWTX $13.03
- ESTA $43.54
- Analyst Decision
- EWTX Buy
- ESTA Buy
- Analyst Count
- EWTX 9
- ESTA 6
- Target Price
- EWTX $39.89
- ESTA $55.50
- AVG Volume (30 Days)
- EWTX 892.5K
- ESTA 404.7K
- Earning Date
- EWTX 08-07-2025
- ESTA 08-05-2025
- Dividend Yield
- EWTX N/A
- ESTA N/A
- EPS Growth
- EWTX N/A
- ESTA N/A
- EPS
- EWTX N/A
- ESTA N/A
- Revenue
- EWTX N/A
- ESTA $170,235,000.00
- Revenue This Year
- EWTX N/A
- ESTA $27.10
- Revenue Next Year
- EWTX N/A
- ESTA $24.55
- P/E Ratio
- EWTX N/A
- ESTA N/A
- Revenue Growth
- EWTX N/A
- ESTA 9.27
- 52 Week Low
- EWTX $10.60
- ESTA $26.56
- 52 Week High
- EWTX $38.12
- ESTA $52.41
- Technical
- Relative Strength Index (RSI)
- EWTX 35.20
- ESTA 71.61
- Support Level
- EWTX $12.72
- ESTA $34.34
- Resistance Level
- EWTX $13.37
- ESTA $38.84
- Average True Range (ATR)
- EWTX 0.65
- ESTA 2.23
- MACD
- EWTX -0.16
- ESTA 0.64
- Stochastic Oscillator
- EWTX 24.22
- ESTA 96.63
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.
About ESTA Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.